However, Remifentanil has not been shown to improve hospital discharge times, post-emergence adverse effect profiles or patient satisfaction, and it has been associated with a higher incidence of intraoperative hypotension and bradycardia.
Sin embargo, el remifentanilo no ha demostrado mejorar el tiempo de descarga hospitalaria, el perfil de efectos adversos post-emergencia ni la satisfacción del paciente y se ha asociado a una mayor incidencia de hipotensión y bradicardia intraoperatoria.